Patent US5037637A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5037637A Expired / Lapsed US ⏱️ 0.0 years remaining

Antibacterial antiplaque, anticalculus oral composition

Assignee: Colgate Palmolive Co
•
Filing: 1989-12-08
•
Granted: 1991-08-06
•
Expires: 2009-12-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An oral composition such as a dentifrice, mouthwash, lozenge or chewing gum containing a polyphosphate anticalculus agent, such as tetraalkali metal pyrophosphate and antibacterial antiplaque agent compatible therewith. The antiplaque agent is a substantially water-insoluble noncationic antibacterial agent such as 2,4,4'-tricholoro-21-hydroxydiphenyl ether (Triclosan).

Inventors

  • 👤 Abaul Gaffar
  • 👤 Nuran Nabi
  • 👤 Brian S. Jannone

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 08:19
CPC Classifications
A; A61; A61Q; A61Q11/00; A61K; A61K8/00; A61K8/18; A61K8/19; A61K8/24; A61K8/30; A61K8/33; A61K8/34; A61K8/347; A61K8/40; A61K8/42; A61K8/72; A61K8/81; A61K8/8164

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 61 words
An oral composition comprising in an orally acceptable vehicle, an effective anticalculus amount of material comprising at least one wholly or partially neutralized alkali metal or ammonium tripolyphosphate or hexametaphosphate salt as anticalculus agent and an effective antiplaque amount of a substantially water insoluble noncationic antibacterial agent selected from the group consisting of halogenated diphenyl ethers, phenolic compounds and halogenated carbanilides.
Claim 2
Dependent Claim 61 words
An oral composition comprising in an orally acceptable vehicle, an effective anticalculus amount of material comprising at least one wholly or partially neutralized alkali metal or ammonium tripolyphosphate or hexametaphosphate salt as anticalculus agent and an effective antiplaque amount of a substantially water insoluble noncationic antibacterial agent selected from the group consisting of halogenated diphenyl ethers, phenolic compounds and halogenated carbanilides.
Claim 3
Dependent Claim 15 words
The oral composition claimed in claim 1 wherein sodium tripolyphosphate is present as anticalculus agent.
Claim 4
Dependent Claim 40 words
The oral composition claimed in claim 1 wherein said at least one salt is present in amount of about 0.1-7% by weight and said substantially water insoluble nonocationic antibacterial agent is present in an amount of about 0.01-5% by weight.
Claim 5
Dependent Claim 16 words
The oral composition claimed in claim 3 wherein said antibacterial agent is a halogenated diphenyl ether.
Claim 6
Dependent Claim 15 words
The oral composition claimed in claim 4 wherein said halogenated diphenyl ether is 2,4,4'-trichloro-2-hydroxy-diphenyl ether.
Claim 7
Dependent Claim 15 words
The oral composition claimed in claim 3 wherein said antibacterial agent is a phenolic compound.
Claim 8
Dependent Claim 17 words
The oral composition claimed in claim 6 wherein said phenolic compound is resorcinol or a derivative thereof.
Claim 9
Dependent Claim 14 words
The oral composition claimed in claim 7 wherein said phenolic compound is hexyl resorcinol.
Claim 10
Dependent Claim 85 words
The oral composition claimed in claim 3 wherein there is present for the purpose of inhibiting hydrolysis of P--O--P bonds in said polyphosphate salts by phosphatase enzymes in saliva to orthophosphates which are relatively ineffective as inhibitors of hydroxyapatite formation, an amount of a fluoride ion source sufficient to supply 25 ppm. to 2,000 ppm. of fluoride ions and 0.05% to 3% of a water-soluble alkali metal or ammonium synthetic anionic linear polymeric polycarboxylate salt having a molecular weight of about 1,000 to about 1,000,000.
Claim 11
Dependent Claim 68 words
The oral composition claimed in claim 9 wherein said fluoride ion source is sodium fluoride and amount sufficient to supply 300 ppm. to 2,000 ppm. of fluoride ions and said polycarboxylate salt is about 0.1 to 2% of a water soluble alkali metal or ammonium salt of a copolymer of vinyl methyl ether and maleic acid or anhydride having a molecular weight of about 30,000 to about 500,000.
Claim 12
Dependent Claim 15 words
The oral composition claimed in claim 3 wherein sodium tripolyphosphate is present as anticalculus agent.
Claim 13
Dependent Claim 14 words
The oral composition claimed in claim 11 wherein said antibacterial agent comprises 2,4,4'-trichloro-2-hydroxydiphenyl ether.
Claim 14
Dependent Claim 15 words
The oral composition claimed in claim 3 wherein sodium hexametaphosphate is present as anticalculus agent.
Claim 15
Dependent Claim 14 words
The oral composition claimed in claim 13 wherein said antibacterial agent comprises 2,4,4'-trichloro-2-hydroxydiphenyl ether.
Claim 16
Dependent Claim 30 words
The oral composition claimed in claim 1 wherein said oral composition contains a dentally acceptable water-insoluble polishing agent and said oral compositions is a toothpowder, dental tablet, toothpaste or dentifrice.
Claim 17
Dependent Claim 50 words
The oral composition claimed in claim 15 wherein said oral composition contains about 10-80% by weight of a liquid phase comprising water and humectant, about 0.1-10% by weight a gelling agent and about 10-75% by weight of said polishing agent and said oral composition is a toothpaste or gel dentifrice.
Claim 18
Dependent Claim 16 words
The oral composition claimed in claim 16 wherein said polishing material is a silica polishing material.
Claim 19
Dependent Claim 27 words
The oral composition claimed in claim 15 wherein said oral composition contains about 70-99% by weight of said polishing material and said oral composition is a toothpowder.
Claim 20
Dependent Claim 41 words
The oral composition claimed in claim 1 wherein said oral composition contains about 90-99.9% by weight of a mixture of water and alcohol in a weight ratio of from about 1:1 to about 20:1 and said oral compositions is a mouthrinse.
Claim 21
Dependent Claim 12 words
The oral composition claimed in claim 19 wherein said alcohol is ethanol.
Claim 22
Dependent Claim 14 words
The oral composition claimed in claim 1 wherein said oral composition is a lozenge.
Claim 23
Dependent Claim 15 words
The oral composition claimed in claim 1 wherein said oral composition is a chewing gum.
Claim 24
Dependent Claim 15 words
The oral composition claimed in claim 1 wherein sodium hexametaphosphate is present as anticalculus agent.
Claim 25
Dependent Claim 71 words
The oral composition comprising about 10-75% by weight of a dentally acceptable water-insoluble polishing agent and an orally acceptable vehicle containing about 10-80% by weight of a liquid phase comprising water and humectant and about 0.1-10% by weight of a gelling agent, said oral composition being a dentifrice and there being present in said orally acceptable vehicle sodium tripolyphosphate anticalculus agent and an effective antiplaque amount of 2,4,4'-trichloro-2-hydroxy-diphenyl ether antibacterial agent.
Claim 26
Dependent Claim 71 words
The oral composition comprising about 10-75% by weight of a dentally acceptable water-insoluble polishing agent and an orally acceptable vehicle containing about 10-80% by weight of a liquid phase comprising water and humectant and about 0.1-10% by weight of a gelling agent, said oral composition being a dentifrice and there being present in said orally acceptable vehicle sodium tripolyphosphate anticalculus agent and an effective antiplaque amount of 2,4,4'-trichloro-2-hydroxy-diphenyl ether antibacterial agent.
Claim 27
Dependent Claim 35 words
The oral composition claimed in claim 24 wherein said sodium tripolypohosphate is present in amount of at least about 0.1-7% by weight and said antibacterial agent is present in amount of about 0.01-5% by weight.
Claim 28
Dependent Claim 87 words
The oral composition claimed in claim 25 wherein there is present for the purpose of inhibiting hydrolysis of P--O--P bonds in said polyphosphate salts by phosphatase enzymes in saliva to polyphosphates which are relatively ineffective as inhibitors of hydroxyapatite formation, an amount of a fluoride ion source sufficient to supply 25 ppm. to 2,000 ppm. of fluoride ions and 0.05% to 3% of a water-soluble alakli metal or ammonium salt of a copolymer of vinyl methyl ether and maleic anhydride having a molecular weight of about 70,000.

References Cited (Backward Citations)

US1943467A Cited
CH506292A Cited
EP0161898A2 Cited
US4627977A Cited
EP0236290A1 Cited
EP0251591A1 Cited
US4980153A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-08-05 1995-02-04 1995-08-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-08-05 1999-02-04 1999-08-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-08-05 2003-02-04 2003-08-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag